Autifony Therapeutics Limited is a UK-based company that specializes in researching treatments for hearing disorders, tinnitus, age-related hearing loss, and schizophrenia. 

Pharmaceutical

Autifony Therapeutics

Autifony Therapeutics' headquarters in Stevenage, United Kingdom

Charles H. Large

Wendy Kennedy Assoc CIPD

Peter Harris

Martin Gunthorpe

Hannah Selin

Barbara Domayne-Hayman

Daniel Umbricht

Sam Williams

Kate Bingham

Atul Pande

John Berriman

Rana Al-Hallaq

The Clinical and Medical Research Team at Autifony Therapeutics focuses on designing and overseeing clinical trials to evaluate the safety and efficacy of novel treatments for hearing disorders and related conditions. This multidisciplinary team, comprising experts in medicinal chemistry and molecular biology, collaborates to analyze data, ensure regulatory compliance, and drive advancements in therapeutic approaches, ultimately aiming to improve patient outcomes in hearing loss and schizophrenia.

Clinical and Medical Research Team

The Leadership Team at Autifony Therapeutics drives the strategic direction and vision of the company, overseeing research and development initiatives aimed at innovative treatments for hearing disorders and schizophrenia. Composed of key executives including the CEO and Chief Medical Officer, the team ensures alignment of business objectives with clinical advancements, fostering collaboration and steering operational effectiveness to achieve the company’s mission.

Leadership Team

Autifony Therapeutics

Org chart

Board & advisors

Teams

Clinical and Medical Research Team

Leadership Team

Offices

Autifony Therapeutics

Org chart

Board & advisors

Teams

Clinical and Medical Research Team

Leadership Team

Offices

Related companies